Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,092 | -6,022 | N/A | N/A | N/A |
| Depreciation Amortization | 64 | 303 | N/A | N/A | N/A |
| Accounts receivable | -166 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 122 | N/A | N/A | N/A | N/A |
| Other Working Capital | -212 | -891 | N/A | N/A | N/A |
| Other Operating Activity | 831 | 1,452 | 0 | 0 | 0 |
| Operating Cash Flow | $-1,453 | $-5,158 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -208 | -129 | N/A | N/A | N/A |
| Investing Cash Flow | $-208 | $-129 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 532 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -18 | 9,345 | 0 | 0 | 0 |
| Financing Cash Flow | $514 | $9,345 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -51 | -13 | N/A | N/A | N/A |
| Beginning Cash Position | 5,139 | 1,094 | N/A | N/A | N/A |
| End Cash Position | 3,941 | 5,139 | N/A | N/A | N/A |
| Net Cash Flow | $-1,198 | $4,045 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,453 | -5,158 | N/A | N/A | N/A |
| Capital Expenditure | -208 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,661 | -5,158 | 0 | 0 | 0 |